Global GLP-1 Agonist Market Research Report 2026(Status and Outlook)
GLP-1 is a polypeptide hormone secreted by the intestine after being stimulated by food. It can stimulate the pancreatic beta cells to secrete insulin and participate in the regulation of blood sugar balance in the human body. However, natural GLP-1 is easily degraded by dipeptidyl peptidase in vivo and loses its activity. In order to make GLP-1 better for clinical application, drug developers have modified its structure and developed a series of GLP-1 receptor agonists. GLP-1 receptor agonists can exert the same biological effects as natural GLP-1, and can also avoid being degraded and inactivated, thereby prolonging the action time.
The global GLP-1 Agonist market size was estimated at USD 20460.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 16.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global GLP-1 Agonist market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global GLP-1 Agonist market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the GLP-1 Agonist market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GLP-1 Agonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of GLP-1 Agonist, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global GLP-1 Agonist market size was estimated at USD 20460.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 16.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global GLP-1 Agonist market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global GLP-1 Agonist market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the GLP-1 Agonist market.
Global GLP-1 Agonist Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Novo Nordisk
- AstraZeneca
- Sanofi
- GSK
- Eli Lilly
- Zealand Pharma A/S
- hansoh
- BENEMAE
Market Segmentation (by Type)
- Long-Acting Drug
- Short-Acting Drug
Market Segmentation (by Application)
- Diabetes
- Obesity
- Nonalcoholic Fatty Liver Disease
- Metabolic Disorder
- Alzheimer's Disease
- Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the GLP-1 Agonist Market
Overview of the regional outlook of the GLP-1 Agonist Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GLP-1 Agonist Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of GLP-1 Agonist, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of GLP-1 Agonist
1.2 Key Market Segments
1.2.1 GLP-1 Agonist Segment by Type
1.2.2 GLP-1 Agonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLP-1 AGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global GLP-1 Agonist Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global GLP-1 Agonist Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLP-1 AGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global GLP-1 Agonist Product Life Cycle
3.3 Global GLP-1 Agonist Sales by Manufacturers (2020-2025)
3.4 Global GLP-1 Agonist Revenue Market Share by Manufacturers (2020-2025)
3.5 GLP-1 Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global GLP-1 Agonist Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 GLP-1 Agonist Market Competitive Situation and Trends
3.8.1 GLP-1 Agonist Market Concentration Rate
3.8.2 Global 5 and 10 Largest GLP-1 Agonist Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GLP-1 AGONIST INDUSTRY CHAIN ANALYSIS
4.1 GLP-1 Agonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLP-1 AGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global GLP-1 Agonist Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to GLP-1 Agonist Market
5.7 ESG Ratings of Leading Companies
6 GLP-1 AGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
6.3 Global GLP-1 Agonist Market Size by Type (2020-2025)
6.4 Global GLP-1 Agonist Price by Type (2020-2025)
7 GLP-1 AGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GLP-1 Agonist Market Sales by Application (2020-2025)
7.3 Global GLP-1 Agonist Market Size (M USD) by Application (2020-2025)
7.4 Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
8 GLP-1 AGONIST MARKET SALES BY REGION
8.1 Global GLP-1 Agonist Sales by Region
8.1.1 Global GLP-1 Agonist Sales by Region
8.1.2 Global GLP-1 Agonist Sales Market Share by Region
8.2 Global GLP-1 Agonist Market Size by Region
8.2.1 Global GLP-1 Agonist Market Size by Region
8.2.2 Global GLP-1 Agonist Market Size by Region
8.3 North America
8.3.1 North America GLP-1 Agonist Sales by Country
8.3.2 North America GLP-1 Agonist Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe GLP-1 Agonist Sales by Country
8.4.2 Europe GLP-1 Agonist Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific GLP-1 Agonist Sales by Region
8.5.2 Asia Pacific GLP-1 Agonist Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America GLP-1 Agonist Sales by Country
8.6.2 South America GLP-1 Agonist Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa GLP-1 Agonist Sales by Region
8.7.2 Middle East and Africa GLP-1 Agonist Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GLP-1 AGONIST MARKET PRODUCTION BY REGION
9.1 Global Production of GLP-1 Agonist by Region(2020-2025)
9.2 Global GLP-1 Agonist Revenue Market Share by Region (2020-2025)
9.3 Global GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America GLP-1 Agonist Production
9.4.1 North America GLP-1 Agonist Production Growth Rate (2020-2025)
9.4.2 North America GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe GLP-1 Agonist Production
9.5.1 Europe GLP-1 Agonist Production Growth Rate (2020-2025)
9.5.2 Europe GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan GLP-1 Agonist Production (2020-2025)
9.6.1 Japan GLP-1 Agonist Production Growth Rate (2020-2025)
9.6.2 Japan GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China GLP-1 Agonist Production (2020-2025)
9.7.1 China GLP-1 Agonist Production Growth Rate (2020-2025)
9.7.2 China GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk GLP-1 Agonist Product Overview
10.1.3 Novo Nordisk GLP-1 Agonist Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca GLP-1 Agonist Product Overview
10.2.3 AstraZeneca GLP-1 Agonist Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi GLP-1 Agonist Product Overview
10.3.3 Sanofi GLP-1 Agonist Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 GSK
10.4.1 GSK Basic Information
10.4.2 GSK GLP-1 Agonist Product Overview
10.4.3 GSK GLP-1 Agonist Product Market Performance
10.4.4 GSK Business Overview
10.4.5 GSK Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly GLP-1 Agonist Product Overview
10.5.3 Eli Lilly GLP-1 Agonist Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Zealand Pharma A/S
10.6.1 Zealand Pharma A/S Basic Information
10.6.2 Zealand Pharma A/S GLP-1 Agonist Product Overview
10.6.3 Zealand Pharma A/S GLP-1 Agonist Product Market Performance
10.6.4 Zealand Pharma A/S Business Overview
10.6.5 Zealand Pharma A/S Recent Developments
10.7 hansoh
10.7.1 hansoh Basic Information
10.7.2 hansoh GLP-1 Agonist Product Overview
10.7.3 hansoh GLP-1 Agonist Product Market Performance
10.7.4 hansoh Business Overview
10.7.5 hansoh Recent Developments
10.8 BENEMAE
10.8.1 BENEMAE Basic Information
10.8.2 BENEMAE GLP-1 Agonist Product Overview
10.8.3 BENEMAE GLP-1 Agonist Product Market Performance
10.8.4 BENEMAE Business Overview
10.8.5 BENEMAE Recent Developments
11 GLP-1 AGONIST MARKET FORECAST BY REGION
11.1 Global GLP-1 Agonist Market Size Forecast
11.2 Global GLP-1 Agonist Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe GLP-1 Agonist Market Size Forecast by Country
11.2.3 Asia Pacific GLP-1 Agonist Market Size Forecast by Region
11.2.4 South America GLP-1 Agonist Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of GLP-1 Agonist by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global GLP-1 Agonist Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of GLP-1 Agonist by Type (2026-2035)
12.1.2 Global GLP-1 Agonist Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of GLP-1 Agonist by Type (2026-2035)
12.2 Global GLP-1 Agonist Market Forecast by Application (2026-2035)
12.2.1 Global GLP-1 Agonist Sales (K MT) Forecast by Application
12.2.2 Global GLP-1 Agonist Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of GLP-1 Agonist
1.2 Key Market Segments
1.2.1 GLP-1 Agonist Segment by Type
1.2.2 GLP-1 Agonist Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GLP-1 AGONIST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global GLP-1 Agonist Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global GLP-1 Agonist Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GLP-1 AGONIST MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global GLP-1 Agonist Product Life Cycle
3.3 Global GLP-1 Agonist Sales by Manufacturers (2020-2025)
3.4 Global GLP-1 Agonist Revenue Market Share by Manufacturers (2020-2025)
3.5 GLP-1 Agonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global GLP-1 Agonist Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 GLP-1 Agonist Market Competitive Situation and Trends
3.8.1 GLP-1 Agonist Market Concentration Rate
3.8.2 Global 5 and 10 Largest GLP-1 Agonist Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GLP-1 AGONIST INDUSTRY CHAIN ANALYSIS
4.1 GLP-1 Agonist Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GLP-1 AGONIST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global GLP-1 Agonist Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to GLP-1 Agonist Market
5.7 ESG Ratings of Leading Companies
6 GLP-1 AGONIST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
6.3 Global GLP-1 Agonist Market Size by Type (2020-2025)
6.4 Global GLP-1 Agonist Price by Type (2020-2025)
7 GLP-1 AGONIST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global GLP-1 Agonist Market Sales by Application (2020-2025)
7.3 Global GLP-1 Agonist Market Size (M USD) by Application (2020-2025)
7.4 Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
8 GLP-1 AGONIST MARKET SALES BY REGION
8.1 Global GLP-1 Agonist Sales by Region
8.1.1 Global GLP-1 Agonist Sales by Region
8.1.2 Global GLP-1 Agonist Sales Market Share by Region
8.2 Global GLP-1 Agonist Market Size by Region
8.2.1 Global GLP-1 Agonist Market Size by Region
8.2.2 Global GLP-1 Agonist Market Size by Region
8.3 North America
8.3.1 North America GLP-1 Agonist Sales by Country
8.3.2 North America GLP-1 Agonist Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe GLP-1 Agonist Sales by Country
8.4.2 Europe GLP-1 Agonist Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific GLP-1 Agonist Sales by Region
8.5.2 Asia Pacific GLP-1 Agonist Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America GLP-1 Agonist Sales by Country
8.6.2 South America GLP-1 Agonist Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa GLP-1 Agonist Sales by Region
8.7.2 Middle East and Africa GLP-1 Agonist Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GLP-1 AGONIST MARKET PRODUCTION BY REGION
9.1 Global Production of GLP-1 Agonist by Region(2020-2025)
9.2 Global GLP-1 Agonist Revenue Market Share by Region (2020-2025)
9.3 Global GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America GLP-1 Agonist Production
9.4.1 North America GLP-1 Agonist Production Growth Rate (2020-2025)
9.4.2 North America GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe GLP-1 Agonist Production
9.5.1 Europe GLP-1 Agonist Production Growth Rate (2020-2025)
9.5.2 Europe GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan GLP-1 Agonist Production (2020-2025)
9.6.1 Japan GLP-1 Agonist Production Growth Rate (2020-2025)
9.6.2 Japan GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China GLP-1 Agonist Production (2020-2025)
9.7.1 China GLP-1 Agonist Production Growth Rate (2020-2025)
9.7.2 China GLP-1 Agonist Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk GLP-1 Agonist Product Overview
10.1.3 Novo Nordisk GLP-1 Agonist Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Basic Information
10.2.2 AstraZeneca GLP-1 Agonist Product Overview
10.2.3 AstraZeneca GLP-1 Agonist Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Sanofi
10.3.1 Sanofi Basic Information
10.3.2 Sanofi GLP-1 Agonist Product Overview
10.3.3 Sanofi GLP-1 Agonist Product Market Performance
10.3.4 Sanofi Business Overview
10.3.5 Sanofi SWOT Analysis
10.3.6 Sanofi Recent Developments
10.4 GSK
10.4.1 GSK Basic Information
10.4.2 GSK GLP-1 Agonist Product Overview
10.4.3 GSK GLP-1 Agonist Product Market Performance
10.4.4 GSK Business Overview
10.4.5 GSK Recent Developments
10.5 Eli Lilly
10.5.1 Eli Lilly Basic Information
10.5.2 Eli Lilly GLP-1 Agonist Product Overview
10.5.3 Eli Lilly GLP-1 Agonist Product Market Performance
10.5.4 Eli Lilly Business Overview
10.5.5 Eli Lilly Recent Developments
10.6 Zealand Pharma A/S
10.6.1 Zealand Pharma A/S Basic Information
10.6.2 Zealand Pharma A/S GLP-1 Agonist Product Overview
10.6.3 Zealand Pharma A/S GLP-1 Agonist Product Market Performance
10.6.4 Zealand Pharma A/S Business Overview
10.6.5 Zealand Pharma A/S Recent Developments
10.7 hansoh
10.7.1 hansoh Basic Information
10.7.2 hansoh GLP-1 Agonist Product Overview
10.7.3 hansoh GLP-1 Agonist Product Market Performance
10.7.4 hansoh Business Overview
10.7.5 hansoh Recent Developments
10.8 BENEMAE
10.8.1 BENEMAE Basic Information
10.8.2 BENEMAE GLP-1 Agonist Product Overview
10.8.3 BENEMAE GLP-1 Agonist Product Market Performance
10.8.4 BENEMAE Business Overview
10.8.5 BENEMAE Recent Developments
11 GLP-1 AGONIST MARKET FORECAST BY REGION
11.1 Global GLP-1 Agonist Market Size Forecast
11.2 Global GLP-1 Agonist Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe GLP-1 Agonist Market Size Forecast by Country
11.2.3 Asia Pacific GLP-1 Agonist Market Size Forecast by Region
11.2.4 South America GLP-1 Agonist Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of GLP-1 Agonist by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global GLP-1 Agonist Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of GLP-1 Agonist by Type (2026-2035)
12.1.2 Global GLP-1 Agonist Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of GLP-1 Agonist by Type (2026-2035)
12.2 Global GLP-1 Agonist Market Forecast by Application (2026-2035)
12.2.1 Global GLP-1 Agonist Sales (K MT) Forecast by Application
12.2.2 Global GLP-1 Agonist Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global GLP-1 Agonist Market Size by Type (M USD)
Table 4. Global GLP-1 Agonist Market Size by Application
Table 5. GLP-1 Agonist Market Size Comparison by Region (M USD)
Table 6. Global GLP-1 Agonist Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global GLP-1 Agonist Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Agonist Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Agonist Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Agonist as of 2025)
Table 11. Global Market GLP-1 Agonist Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global GLP-1 Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. GLP-1 Agonist Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global GLP-1 Agonist Sales by Type (K MT)
Table 27. Global GLP-1 Agonist Market Size by Type (M USD)
Table 28. Global GLP-1 Agonist Sales (K MT) by Type (2020-2025)
Table 29. Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
Table 30. Global GLP-1 Agonist Market Size (M USD) by Type (2020-2025)
Table 31. Global GLP-1 Agonist Market Share by Type (2020-2025)
Table 32. Global GLP-1 Agonist Price (USD/KG) by Type (2020-2025)
Table 33. Global GLP-1 Agonist Sales (K MT) by Application
Table 34. Global GLP-1 Agonist Market Size by Application
Table 35. Global GLP-1 Agonist Sales by Application (2020-2025) & (K MT)
Table 36. Global GLP-1 Agonist Sales Market Share by Application (2020-2025)
Table 37. Global GLP-1 Agonist Market Size by Application (2020-2025) & (M USD)
Table 38. Global GLP-1 Agonist Market Share by Application (2020-2025)
Table 39. Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
Table 40. Global GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 41. Global GLP-1 Agonist Sales Market Share by Region (2020-2025)
Table 42. Global GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 43. Global GLP-1 Agonist Market Size by Region (2020-2025)
Table 44. North America GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 45. North America GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 46. Europe GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 47. Europe GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 50. South America GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 51. South America GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 54. Global GLP-1 Agonist Production (K MT) by Region(2020-2025)
Table 55. Global GLP-1 Agonist Revenue (US$ Million) by Region (2020-2025)
Table 56. Global GLP-1 Agonist Revenue Market Share by Region (2020-2025)
Table 57. Global GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk GLP-1 Agonist Product Overview
Table 64. Novo Nordisk GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. AstraZeneca Basic Information
Table 69. AstraZeneca GLP-1 Agonist Product Overview
Table 70. AstraZeneca GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca SWOT Analysis
Table 73. AstraZeneca Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi GLP-1 Agonist Product Overview
Table 76. Sanofi GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. GSK Basic Information
Table 81. GSK GLP-1 Agonist Product Overview
Table 82. GSK GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. GSK Business Overview
Table 84. GSK Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly GLP-1 Agonist Product Overview
Table 87. Eli Lilly GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Zealand Pharma A/S Basic Information
Table 91. Zealand Pharma A/S GLP-1 Agonist Product Overview
Table 92. Zealand Pharma A/S GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zealand Pharma A/S Business Overview
Table 94. Zealand Pharma A/S Recent Developments
Table 95. hansoh Basic Information
Table 96. hansoh GLP-1 Agonist Product Overview
Table 97. hansoh GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. hansoh Business Overview
Table 99. hansoh Recent Developments
Table 100. BENEMAE Basic Information
Table 101. BENEMAE GLP-1 Agonist Product Overview
Table 102. BENEMAE GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BENEMAE Business Overview
Table 104. BENEMAE Recent Developments
Table 105. Global GLP-1 Agonist Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global GLP-1 Agonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific GLP-1 Agonist Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific GLP-1 Agonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa GLP-1 Agonist Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global GLP-1 Agonist Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global GLP-1 Agonist Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global GLP-1 Agonist Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global GLP-1 Agonist Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global GLP-1 Agonist Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global GLP-1 Agonist Market Size by Type (M USD)
Table 4. Global GLP-1 Agonist Market Size by Application
Table 5. GLP-1 Agonist Market Size Comparison by Region (M USD)
Table 6. Global GLP-1 Agonist Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global GLP-1 Agonist Sales Market Share by Manufacturers (2020-2025)
Table 8. Global GLP-1 Agonist Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global GLP-1 Agonist Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Agonist as of 2025)
Table 11. Global Market GLP-1 Agonist Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global GLP-1 Agonist Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. GLP-1 Agonist Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global GLP-1 Agonist Sales by Type (K MT)
Table 27. Global GLP-1 Agonist Market Size by Type (M USD)
Table 28. Global GLP-1 Agonist Sales (K MT) by Type (2020-2025)
Table 29. Global GLP-1 Agonist Sales Market Share by Type (2020-2025)
Table 30. Global GLP-1 Agonist Market Size (M USD) by Type (2020-2025)
Table 31. Global GLP-1 Agonist Market Share by Type (2020-2025)
Table 32. Global GLP-1 Agonist Price (USD/KG) by Type (2020-2025)
Table 33. Global GLP-1 Agonist Sales (K MT) by Application
Table 34. Global GLP-1 Agonist Market Size by Application
Table 35. Global GLP-1 Agonist Sales by Application (2020-2025) & (K MT)
Table 36. Global GLP-1 Agonist Sales Market Share by Application (2020-2025)
Table 37. Global GLP-1 Agonist Market Size by Application (2020-2025) & (M USD)
Table 38. Global GLP-1 Agonist Market Share by Application (2020-2025)
Table 39. Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
Table 40. Global GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 41. Global GLP-1 Agonist Sales Market Share by Region (2020-2025)
Table 42. Global GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 43. Global GLP-1 Agonist Market Size by Region (2020-2025)
Table 44. North America GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 45. North America GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 46. Europe GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 47. Europe GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 50. South America GLP-1 Agonist Sales by Country (2020-2025) & (K MT)
Table 51. South America GLP-1 Agonist Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa GLP-1 Agonist Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa GLP-1 Agonist Market Size by Region (2020-2025) & (M USD)
Table 54. Global GLP-1 Agonist Production (K MT) by Region(2020-2025)
Table 55. Global GLP-1 Agonist Revenue (US$ Million) by Region (2020-2025)
Table 56. Global GLP-1 Agonist Revenue Market Share by Region (2020-2025)
Table 57. Global GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China GLP-1 Agonist Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk GLP-1 Agonist Product Overview
Table 64. Novo Nordisk GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. AstraZeneca Basic Information
Table 69. AstraZeneca GLP-1 Agonist Product Overview
Table 70. AstraZeneca GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. AstraZeneca Business Overview
Table 72. AstraZeneca SWOT Analysis
Table 73. AstraZeneca Recent Developments
Table 74. Sanofi Basic Information
Table 75. Sanofi GLP-1 Agonist Product Overview
Table 76. Sanofi GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Sanofi Business Overview
Table 78. Sanofi SWOT Analysis
Table 79. Sanofi Recent Developments
Table 80. GSK Basic Information
Table 81. GSK GLP-1 Agonist Product Overview
Table 82. GSK GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. GSK Business Overview
Table 84. GSK Recent Developments
Table 85. Eli Lilly Basic Information
Table 86. Eli Lilly GLP-1 Agonist Product Overview
Table 87. Eli Lilly GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Recent Developments
Table 90. Zealand Pharma A/S Basic Information
Table 91. Zealand Pharma A/S GLP-1 Agonist Product Overview
Table 92. Zealand Pharma A/S GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Zealand Pharma A/S Business Overview
Table 94. Zealand Pharma A/S Recent Developments
Table 95. hansoh Basic Information
Table 96. hansoh GLP-1 Agonist Product Overview
Table 97. hansoh GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. hansoh Business Overview
Table 99. hansoh Recent Developments
Table 100. BENEMAE Basic Information
Table 101. BENEMAE GLP-1 Agonist Product Overview
Table 102. BENEMAE GLP-1 Agonist Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. BENEMAE Business Overview
Table 104. BENEMAE Recent Developments
Table 105. Global GLP-1 Agonist Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global GLP-1 Agonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific GLP-1 Agonist Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific GLP-1 Agonist Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America GLP-1 Agonist Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa GLP-1 Agonist Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa GLP-1 Agonist Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global GLP-1 Agonist Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global GLP-1 Agonist Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global GLP-1 Agonist Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global GLP-1 Agonist Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global GLP-1 Agonist Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of GLP-1 Agonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global GLP-1 Agonist Market Size (M USD), 2025-2035
Figure 5. Global GLP-1 Agonist Market Size (M USD) (2020-2035)
Figure 6. Global GLP-1 Agonist Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. GLP-1 Agonist Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global GLP-1 Agonist Product Life Cycle
Figure 13. GLP-1 Agonist Sales Share by Manufacturers in 2025
Figure 14. Global GLP-1 Agonist Revenue Share by Manufacturers in 2025
Figure 15. GLP-1 Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market GLP-1 Agonist Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by GLP-1 Agonist Revenue in 2025
Figure 18. Industry Chain Map of GLP-1 Agonist
Figure 19. Global GLP-1 Agonist Market PEST Analysis
Figure 20. Global GLP-1 Agonist Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global GLP-1 Agonist Market Share by Type
Figure 27. Sales Market Share of GLP-1 Agonist by Type (2020-2025)
Figure 28. Sales Market Share of GLP-1 Agonist by Type in 2025
Figure 29. Market Share of GLP-1 Agonist by Type (2020-2025)
Figure 30. Market Share of GLP-1 Agonist by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global GLP-1 Agonist Market Share by Application
Figure 33. Global GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 34. Global GLP-1 Agonist Sales Market Share by Application in 2025
Figure 35. Global GLP-1 Agonist Market Share by Application (2020-2025)
Figure 36. Global GLP-1 Agonist Market Share by Application in 2025
Figure 37. Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
Figure 38. Global GLP-1 Agonist Sales Market Share by Region (2020-2025)
Figure 39. Global GLP-1 Agonist Market Size by Region (2020-2025)
Figure 40. North America GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America GLP-1 Agonist Sales Market Share by Country in 2024
Figure 43. North America GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America GLP-1 Agonist Market Size by Country in 2024
Figure 45. U.S. GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada GLP-1 Agonist Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada GLP-1 Agonist Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico GLP-1 Agonist Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico GLP-1 Agonist Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe GLP-1 Agonist Sales Market Share by Country in 2024
Figure 53. Europe GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe GLP-1 Agonist Market Size by Country in 2024
Figure 55. Germany GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 66. Asia Pacific GLP-1 Agonist Sales Market Share by Region in 2024
Figure 67. Asia Pacific GLP-1 Agonist Market Size by Region in 2024
Figure 68. China GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 79. South America GLP-1 Agonist Sales Market Share by Country in 2024
Figure 80. South America GLP-1 Agonist Market Size and Growth Rate (M USD)
Figure 81. South America GLP-1 Agonist Market Size by Country in 2024
Figure 82. Brazil GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa GLP-1 Agonist Sales Market Share by Region in 2024
Figure 90. Middle East and Africa GLP-1 Agonist Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa GLP-1 Agonist Market Size by Region in 2024
Figure 92. Saudi Arabia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global GLP-1 Agonist Production Market Share by Region (2020-2025)
Figure 103. North America GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 106. China GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 107. Global GLP-1 Agonist Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global GLP-1 Agonist Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global GLP-1 Agonist Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global GLP-1 Agonist Market Share Forecast by Type (2026-2035)
Figure 111. Global GLP-1 Agonist Sales Forecast by Application (2026-2035)
Figure 112. Global GLP-1 Agonist Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of GLP-1 Agonist
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global GLP-1 Agonist Market Size (M USD), 2025-2035
Figure 5. Global GLP-1 Agonist Market Size (M USD) (2020-2035)
Figure 6. Global GLP-1 Agonist Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. GLP-1 Agonist Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global GLP-1 Agonist Product Life Cycle
Figure 13. GLP-1 Agonist Sales Share by Manufacturers in 2025
Figure 14. Global GLP-1 Agonist Revenue Share by Manufacturers in 2025
Figure 15. GLP-1 Agonist Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market GLP-1 Agonist Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by GLP-1 Agonist Revenue in 2025
Figure 18. Industry Chain Map of GLP-1 Agonist
Figure 19. Global GLP-1 Agonist Market PEST Analysis
Figure 20. Global GLP-1 Agonist Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global GLP-1 Agonist Market Share by Type
Figure 27. Sales Market Share of GLP-1 Agonist by Type (2020-2025)
Figure 28. Sales Market Share of GLP-1 Agonist by Type in 2025
Figure 29. Market Share of GLP-1 Agonist by Type (2020-2025)
Figure 30. Market Share of GLP-1 Agonist by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global GLP-1 Agonist Market Share by Application
Figure 33. Global GLP-1 Agonist Sales Market Share by Application (2020-2025)
Figure 34. Global GLP-1 Agonist Sales Market Share by Application in 2025
Figure 35. Global GLP-1 Agonist Market Share by Application (2020-2025)
Figure 36. Global GLP-1 Agonist Market Share by Application in 2025
Figure 37. Global GLP-1 Agonist Sales Growth Rate by Application (2020-2025)
Figure 38. Global GLP-1 Agonist Sales Market Share by Region (2020-2025)
Figure 39. Global GLP-1 Agonist Market Size by Region (2020-2025)
Figure 40. North America GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America GLP-1 Agonist Sales Market Share by Country in 2024
Figure 43. North America GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America GLP-1 Agonist Market Size by Country in 2024
Figure 45. U.S. GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada GLP-1 Agonist Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada GLP-1 Agonist Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico GLP-1 Agonist Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico GLP-1 Agonist Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe GLP-1 Agonist Sales Market Share by Country in 2024
Figure 53. Europe GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe GLP-1 Agonist Market Size by Country in 2024
Figure 55. Germany GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 66. Asia Pacific GLP-1 Agonist Sales Market Share by Region in 2024
Figure 67. Asia Pacific GLP-1 Agonist Market Size by Region in 2024
Figure 68. China GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 79. South America GLP-1 Agonist Sales Market Share by Country in 2024
Figure 80. South America GLP-1 Agonist Market Size and Growth Rate (M USD)
Figure 81. South America GLP-1 Agonist Market Size by Country in 2024
Figure 82. Brazil GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa GLP-1 Agonist Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa GLP-1 Agonist Sales Market Share by Region in 2024
Figure 90. Middle East and Africa GLP-1 Agonist Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa GLP-1 Agonist Market Size by Region in 2024
Figure 92. Saudi Arabia GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa GLP-1 Agonist Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa GLP-1 Agonist Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global GLP-1 Agonist Production Market Share by Region (2020-2025)
Figure 103. North America GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 106. China GLP-1 Agonist Production (K MT) Growth Rate (2020-2025)
Figure 107. Global GLP-1 Agonist Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global GLP-1 Agonist Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global GLP-1 Agonist Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global GLP-1 Agonist Market Share Forecast by Type (2026-2035)
Figure 111. Global GLP-1 Agonist Sales Forecast by Application (2026-2035)
Figure 112. Global GLP-1 Agonist Market Share Forecast by Application (2026-2035)
